The groundbreaking treatment of the medication represents a exciting advance in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects multiple pathways – GLP-1 and the GIP hormone https://tirzepatidepeptide691077.fitnell.com/83135895/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment